全文获取类型
收费全文 | 154篇 |
免费 | 8篇 |
国内免费 | 25篇 |
专业分类
儿科学 | 5篇 |
妇产科学 | 1篇 |
基础医学 | 6篇 |
口腔科学 | 10篇 |
临床医学 | 28篇 |
内科学 | 40篇 |
皮肤病学 | 4篇 |
神经病学 | 3篇 |
特种医学 | 32篇 |
外科学 | 8篇 |
综合类 | 6篇 |
预防医学 | 12篇 |
药学 | 27篇 |
肿瘤学 | 5篇 |
出版年
2022年 | 1篇 |
2020年 | 1篇 |
2018年 | 1篇 |
2017年 | 2篇 |
2016年 | 2篇 |
2015年 | 7篇 |
2014年 | 2篇 |
2013年 | 3篇 |
2012年 | 2篇 |
2011年 | 4篇 |
2010年 | 8篇 |
2009年 | 13篇 |
2008年 | 3篇 |
2007年 | 22篇 |
2006年 | 5篇 |
2005年 | 2篇 |
2004年 | 2篇 |
2003年 | 1篇 |
2001年 | 5篇 |
2000年 | 5篇 |
1999年 | 2篇 |
1998年 | 8篇 |
1997年 | 11篇 |
1996年 | 7篇 |
1995年 | 2篇 |
1994年 | 8篇 |
1993年 | 7篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1989年 | 5篇 |
1988年 | 6篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 6篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 1篇 |
排序方式: 共有187条查询结果,搜索用时 15 毫秒
61.
肠源性内毒素血症与肝病 总被引:30,自引:4,他引:26
近年来,肠源性内毒素血症(intestinal endotoxemia,IETM)与肝病的关系日益受到重视.临床观察表明,各种急、慢性肝炎、肝硬变和重型肝炎患者内毒素血症(endotoxemia,ETM)发生率有不同程度升高.内毒素与肝损害之间存在着密切的关系[1-3].二者可互为因果,从而对肝病的发生发展产生重要影响.特别是内毒素作用于肝脏后,引起多种细胞因子分泌与释放,导致肝脏损害进一步加重,甚至出现黄疸、出血、肾功能衰竭与肝性脑病等肝功能衰竭临床综合征. 相似文献
62.
Small lesions in the heart identified at electron beam CT: calcification or noise? 总被引:11,自引:0,他引:11
Bielak LF; Kaufmann RB; Moll PP; McCollough CH; Schwartz RS; Sheedy PF nd 《Radiology》1994,192(3):631
63.
64.
65.
66.
67.
RG Strauss ; LF Burmeister ; K Johnson ; T James ; J Miller ; DG Cordle ; EF Bell ; GA Ludwig 《Transfusion》1996,36(10):873-878
BACKGROUND: Despite recent optimism about the use of erythropoietin therapy to treat the anemia of prematurity, very-low-birth-weight infants who are severely ill receive multiple red cell (RBC) transfusions. Many physicians transfuse relatively fresh RBCs to newborn infants, exposing them to multiple donors and possibly increasing their risk of acquiring transfusion-transmitted infections. STUDY DESIGN AND METHODS: A randomized, single-blind clinical trial was conducted to determine, as the primary endpoint, whether RBCs collected from one dedicated donor and stored for < or = 42 days in AS-1 storage media could safely supply all small-volume RBC transfusions (15 mL/kg/dose) needed by very-low-birth-weight infants (0.6-1.3 kg) during the first 84 days of life. Secondary endpoints were the assessment of the possible adverse clinical and biochemical effects of transfusing AS- 1 RBCs stored for < or = 42 days. Control infants received identical nursery care, except they received fresh RBCs stored < or = 7 days in CPDA-1. RESULTS: Infants transfused with AS-1 RBCs were exposed to a mean of 1.6 donors,-compared with an exposure to 3.7 donors for infants given CPDA-1 RBCs (p < 0.05). Neither clinical transfusion reactions nor the results of multiple laboratory tests were significantly different in infants who received slow transfusions (15 mL/kg) of AS-1 RBCs stored for < or = 42 days and in infants who received the same volume of CPDA-1 RBCs stored < or = 7 days. CONCLUSION: AS-1 RBCs, usually from only one dedicated donor, can safely supply all RBCs needed by most very-low-birth-weight infants-a practice that decreases donor exposure and likely increases transfusion safety. 相似文献
68.
Jill R Turner Derek S Wilkinson Rachel LF Poole Thomas J Gould Gregory C Carlson Julie A Blendy 《Neuropsychopharmacology》2013,38(10):2035-2047
Smoking is the largest preventable cause of death in the United States. Furthermore, a recent study found that <10% of quit attempts resulted in continuous abstinence for 1 year. With the introduction of pharmacotherapies like Chantix (varenicline), a selective α4β2 nicotinic partial agonist, successful quit attempts have significantly increased. Therefore, novel subtype-specific nicotinic drugs, such as sazetidine-A, present a rich area for investigation of therapeutic potential in smoking cessation. The present studies examine the anxiety-related behavioral and functional effects of the nicotinic partial agonists varenicline and sazetidine-A during withdrawal from chronic nicotine in mice. Our studies indicate that ventral hippocampal-specific infusions of sazetidine-A, but not varenicline, are efficacious in reducing nicotine withdrawal-related anxiety-like phenotypes in the novelty-induced hypophagia (NIH) paradigm. To further investigate functional differences between these partial agonists, we utilized voltage-sensitive dye imaging (VSDi) in ventral hippocampal slices to determine the effects of sazetidine-A and varenicline in animals chronically treated with saline, nicotine, or undergoing 24 h withdrawal. These studies demonstrate a functional dissociation of varenicline and sazetidine-A on hippocampal network activity, which is directly related to previous drug exposure. Furthermore, the effects of the nicotinic partial agonists in VSDi assays are significantly correlated with their behavioral effects in the NIH test. These findings highlight the importance of drug history in understanding the mechanisms through which nicotinic compounds may be aiding smoking cessation in individuals experiencing withdrawal-associated anxiety. 相似文献
69.
Filipe LF. Carvalho Brian W. Simons Emmanuel S. Antonarakis Zeshaan Rasheed Nora Douglas Daniela Villegas William Matsui David M. Berman 《Oncotarget》2013,4(3):413-421
Circulating tumor cells (CTCs) have received intense scientific scrutiny because they travel in the bloodstream and are therefore well situated to mediate hematogenous metastasis. However, the potential of CTCs to actually form new tumors has not been tested. Popular methods of isolating CTCs are biased towards larger, more differentiated, non-viable cells, creating a barrier to testing their tumor forming potential. Without relying on cell size or the expression of differentiation markers, our objective was to isolate viable prostate CTCs from mice and humans and assay their ability to initiate new tumors. Therefore, blood was collected from transgenic adenocarcinoma of the mouse prostate (TRAMP) mice and from human patients with metastatic castration-resistant prostate cancer (PCa). Gradient density centrifugation or red cell lysis was used to remove erythrocytes, and then leukocytes were depleted by magnetic separation using CD45 immunoaffinity beads. CTCs fractions from TRAMP mice and PCa patients were verified by immunocytochemical staining for cytokeratin 8 and EpCAM, and inoculated into immunodeficient mice. TRAMP tumor growth was monitored by palpation. Human tumor growth formation was monitored up to 8 months by ultrasensitive PSA assays performed on mouse serum. We found viable tumor cells present in the bloodstream that were successfully isolated from mice without relying on cell surface markers. Two out of nine immunodeficient mice inoculated with TRAMP CTCs developed massive liver metastases. CTCs were identified in blood from PCa patients but did not form tumors. In conclusion, viable CTCs can be isolated without relying on epithelial surface markers or size fractionation. TRAMP CTCs were tumorigenic, so CTCs isolated in this way contain viable tumor-initiating cells. Only two of nine hosts grew TRAMP tumors and none of the human CTCs formed tumors, which suggests that most CTCs have relatively low tumor-forming potential. Future studies should identify and target the highly tumorigenic cells. 相似文献
70.
M Reyes-Lugo M Reyes-Contreras I Salvi W Gelves A Avilán D Llavaneras LF Navarrete G Cordero EE Sánchez A Rodríguez-Acosta 《Asian Pacific Journal of Tropical Biomedicine》2011,1(4):279-284